International Cannabis Weekly: 461

NEW REPORT: GERMANY’S CANNABIS MARKET CROSSES €1.15BN AS REIMBURSEMENT ERA ENDS

Germany’s medical cannabis market reached approximately €1.15bn in 2026, with private self-pay prescriptions now generating around 75% of total market value, according to a new whitepaper published today by Business of Cannabis and Prohibition Partners.

READ MORE  »

US HEMP INDUSTRY WINS A STAY OF EXECUTION AS SENATE DELAYS BAN UNTIL DECEMBER

READ MORE »

THAILAND PRESSES MEDICAL-ONLY CANNABIS BILL TOWARD CABINET

READ MORE »

• Hamburg reports 17 cannabis cultivation associations with only one advertising violation since legalisation.
• Berlin’s Hanfparade will celebrate its 30th anniversary with another major cannabis rights demonstration.
• Italy’s hemp flower ban faces renewed legal scrutiny following Supreme Court confiscation ruling.
• Medical cannabis compound shows promising results in reducing PTSD-related nightmares in new research.
• German cannabis cultivation associations secure another legal victory in Freiburg court decision.

LEARN MORE »

• North Carolina governor urges lawmakers to create a regulated cannabis market instead of restricting hemp.
• Texas businesses and consumers face major disruption as statewide THC products ban takes effect.
• Virginia hemp businesses file lawsuit challenging new state limits on THC products.
• Cannabis rescheduling’s R&E credit opportunities have obstacles, according to reports.
• Utah opens applications for new independent medical cannabis pharmacy licence in underserved region.
• Delaware cannabis sales reach $53.4 million during the legal market’s first full year.
• Teamsters declare victory after concluding the largest cannabis industry strike in United States history.

• High Tide secures $40 million through new senior secured credit facilities to support growth.
• SNDL successfully completes EU GMP audit at Atholville facility to strengthen export opportunities.
• High Tide issues preliminary third quarter 2026 guidance highlighting continued business momentum.
• Cannabis NB sales cool despite continued strength in the fast-growing pre-roll category.
• High Tide completes Northern Helm acquisition to expand retail network with four additional stores.
• Decibel Cannabis announces date for releasing its second quarter 2026 financial results.

• Uruguay increases the retail price of legal cannabis sold through the national programme.
• Brazil’s new ANVISA regulations governing cannabis cultivation officially come into force today.
• Panama introduces new cannabis regulations as the country continues advancing its medical market.
• Brazil maintains a dedicated pathway allowing patients to import medical cannabis products.

• New South Wales strengthens its leadership in hemp construction through fresh investment initiatives.
• South Korea invests $21 million into research on minor hemp-derived cannabinoids and new therapies.
• Sociodemographic trends in daily, weekly and less than weekly cannabis use in Australia.
• Nepal’s Gandaki Province legalises medical cannabis cultivation and use in landmark regional reform.
• French Polynesia prepares to launch its long-delayed medical cannabis pilot programme after months of delays.

• Eswatini joins southern Africa’s growing movement towards developing a regulated industrial hemp sector.
• Ghanaian stakeholders renew calls for greater investment and development across the country’s cannabis industry.